Tirzepatide is administered as a once-weekly subcutaneous injection, with doses gradually titrated from 2.5 mg up to a maximum of 15 mg over several months
Through the Care360 model and integrated patient portal, patients may optionally connect health data from compatible devices and applications, including Apple Health, Apple Watch, Google Health Connect, and Google Fit, enabling the care team to review activity levels, weight trends, heart rate, nutrition, and other wellness metrics to inform personalized care
Because hemophilia presents unique challenges related to bleeding and joint health, its important to have a thorough discussion with a healthcare provider before starting any new medication
Studies in rats suggest that berberine increases GLP-1 secretion
In a randomized crossover study of 14 patients with OSA, desipramine, for example, demonstrated a reduction in airway collapsibility that translated to a modest improvement in AHI in patients with minimal upper airway compensation at baseline [78, 79]
A brief pause of a few days does not undo weight loss progress or reverse metabolic benefits